ONCO Stock Price Chart
ONCO Earnings
Onconetix Inc
$0.38
-5.94%
$-0.02
At close: May 08, 16:00:00 GMT-4
$0.37
-1.31%
$0
Pre-market: May 11, 05:35:51 GMT-4
Back
Onconetix Inc (ONCO) Earnings
Key Stats
Prev.Close
$0.404
Open
$0.3955
Day's Range
$0.36 - $0.4
52 week range
$0.375 - $74.3
Volume
852.2K
Avg.Volume
5.1M
Dividend yield
--
EPS (TTM)
-74.35
Market Cap
$258.7K
What is ONCO?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
